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advantage. Also, it was an advantage
that we were able to take within-person
correlation into account to avoid artifi-
cial estimates. This study also had some
limitations. The study population were
women who had participated in the first
pregnancy interview, which took place
early in the second trimester, and the
risk of fetal deaths in the first trimester—
which constitute the largest proportion
of fetal deaths—could therefore not be
estimated. In this study, information on
psoriasis was self-reported. This could
have introduced misclassification of
mothers with psoriasis, but it was prob-
ably confined to women who had mild
psoriasis and were misclassified as
unexposed. This might have driven the
association toward displaying no differ-
ence between women with and without
psoriasis. In the DNBC, there was no
information on the severity of psoriasis.
We had no access to information
regarding psoriasis treatment before or
during pregnancy. However, most likely
only a few women—if any—were given
systemic treatments as these treatments
are normally avoided for women of
childbearing age. An issue when study-
ing TTP, is the fact that only women
who achieve pregnancy are included.
This excludes a whole group of women
who never become pregnant.
In conclusion, in this large prospec-
tive cohort study we found that psoriasis
was not a risk factor for fetal death after
the first trimester or for prolonged TTP in
patients with mainly mild to moderate
psoriasis.
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TO THE EDITOR
Our understanding of skin biology has
been greatly enhanced by studying gen-
odermatoses, as this has guided the
discovery of key genes responsible for
skin function (Chamcheu et al., 2011).
Palmoplantar keratodermas (PPKs) are a
group of rare, heterogeneous hereditary
diseases characterized by epidermal
hyperkeratosis of palmoplantar skin.
They are typically classified according
to their mode of inheritance or morpho-
logic features of the disease. However,
the clinical picture is often complicated
by significant interfamilial and intrafa-
milial variation in lesional appearance
(Kelsell and Stevens, 1999).
In this study, we focused on punctate
palmoplantar keratoderma type 1
(PPKP1), also known as punctate PPK,
or Buschke–Fischer–Brauer (OMIM
148600). The inheritance of punctate
PPK is commonly autosomal dominant;
however, it sometimes presents as an
acquired disease (Emmert et al., 2003).Accepted article preview online 3 January 2014; published online 30 January 2014
Abbreviation: PPK/PPKP1, palmoplantar keratoderma/palmoplantar keratoderma, punctate, type 1
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The onset of punctate PPK is usually
observed between 10 and 45 years of
age, with the number and severity of
lesions increasing with advancing age.
Lesions present as multiple small,
yellow, hyperkeratotic papules with
central indentation and are irregularly
distributed. Typically, there is an
increased confluence of lesions over
areas of high pressure, such as on the
soles of the feet, whereas the punctate
morphology is more evident on the
palms (Figure 1a). There is an absence
of inflammatory changes, and only
rarely are there nail findings observed
in punctate PPK. Notably, punctate PPK
has been reported to be associated with
an increased incidence of squamous
cell carcinomas, as well as early- and
late-onset malignancies, such as Hodg-
kin’s disease, renal, breast, pancreatic,
and colonic adenocarcinomas (Bennion
and Patterson, 1984; Kelsell and
Stevens, 1999).
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Figure 1. Mutations in AAGAB underlie punctate palmoplantar keratoderma (PPK). (a) Representative photographs of patients with punctate PPK. Note the
disproportionate involvement of the soles over the palms, and the high degree of phenotypic variability between patients. (b) Summary and location of AAGAB
mutations identified within this and previous studies. Mutations on the top half of the diagram are those identified within this study (red indicates novel mutations,
whereas black indicates mutations that have been previously described). On the bottom half of the diagram are mutations that have been identified in previous
studies. Within the AAGAB protein, the locations of the GTPase and adaptin-binding domains are indicated, as are the locations of the 10 exons.
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Ten years ago, mutations in more
than 15 genes had been identified in
different forms of PPK; however, the
pathogenic mutations underlying punc-
tate PPK were unknown. We previously
reported three large pedigrees from
Israel and Mexico, punctate PPK, and
mapped the affected locus to chromo-
some 15q22–24 using linkage analysis
(Martinez-Mir et al., 2003).
Recently, two groups simultaneously
identified several loss-of-function
mutations in a single gene, AAGAB, in
multiple families of different ancestries
with punctate PPK (Giehl et al., 2012;
Pohler et al., 2012). AAGAB encodes
the a- and g-adaptin-binding protein
p34, and is located on chromosome
15q.22, within our previously identi-
fied linkage region (Martinez-Mir et al.,
2003). Four subsequent studies have
described mutations in AAGAB that
underlie punctate PPK in several new
families (Cui et al., 2013; Kiritsi et al.,
2013; Li et al., 2013; Pohler et al.,
2013). In light of these findings, we
sequenced the whole AAGAB gene in
our cohort of 11 families with punctate
PPK (Supplementary Figures S1–S11
online). The pedigrees of PPK01–
PPK03 were previously documented, in
our linkage studies (Martinez-Mir et al.,
2003). We sequenced PPK01 and
PPK02, which are of Israeli and Arab-
Israeli origin, for mutations in AAGAB.
Further, we sequenced AAGAB in an
additional nine new families with
punctate PPK, which were designated
PPK04–PPK12. Of these, two were from
Israel, one was from Canada, and six
were from Slovenia. In Slovenia, the
incidence of punctate PPK is 3.3/
100,000, making it extremely prevalent
in this population, compared with the
twofold lower incidence of 1.17/
100,000 in the neighboring Croatian
population (Stanimirovic et al., 1993;
Miljkovic and Kansky, 2009).
Genomic DNA was obtained from
blood samples collected following
informed consent in accordance with
IRB regulations at Columbia University
and the Declaration of Helsinki Princi-
ples. We used Sanger Sequencing to
sequence the AAGAB gene in patients
from each of our families, using primers
previously described for this gene
(Pohler et al., 2012). Pedigrees, sequenc-
ing results, and photographs of each
family can be found in the Supple-
mentary results. We found 7 distinct
pathogenic mutations within 11 families,
of which 5 are previously unreported to
our knowledge (Figure 1b). These were
all heterozygous, consistent with an
autosomal dominant pattern of inheri-
tance. Mutations segregated with the
disease phenotype in all but one unaff-
ected individual where a heterozygous
mutation was detected. Presumably this
patient had not yet manifested the phe-
notype (Supplementary Figure S4
online).
Of the seven identified mutations
(Table 1), we found one, c.481C4T:
p.R161X, in four families (three from
Slovenia and one from Israel). This
mutation was previously described as a
founder mutation in families of Croatian
origin (Giehl et al., 2012), and was also
observed within Scottish and Chinese
families (Pohler et al., 2012; Cui et al.,
2013; Kiritsi et al., 2013). Moreover, the
mutation in our Canadian family,
c.472delG; p.G158Efs*1, was pre-
viously found in five families of
Scottish origin (Pohler et al., 2012). To
our knowledge the other five mutations
identified in this study have not been
reported elsewhere to date. Of these,
one mutation, c.566C4G, p.S189X,
was found in two families of Slovenian
origin, whereas the remaining four
mutations, which were all predicted
to cause frameshifts in the protein,
were each unique to a single family.
Substantial phenotypic variability was
noted between patients who carried
the same mutation, ranging from very
mild to extensively hyperkeratotic
presentations of the disease. Although
this indicates that environmental factors
and personal skin care regimens may
affect the degree of hyperkeratosis, it is
not uncommon for dominantly inherited
diseases to exhibit such variable
expressivity.
AAGAB consists of 10 exons with a
coding sequence of 945 nucleotides, and
it codes for the a- and g-adaptin-binding
protein p34 (Pohler et al., 2012). p34 has
a role in membrane trafficking, and as a
result of AAGAB mutations, deficiencies
in p34 lead to impaired endocytic
recycling of EGFR proteins, which in
turn leads to cellular hyperproliferation
(Pohler et al., 2012). Cellular hyperproli-
feration is postulated to be at least one
cause of the hyperkeratotic lesions
observed in punctate PPK.
In summary, to our knowledge we
identified five previously unreported
mutations and two recurrent mutations
of the AAGAB gene, which underlie
punctate PPK. There are now a total of
22 mutations in AAGAB that have been
Table 1. Summary of mutations in AAGAB gene found in 11 families with punctate PPK
DNA mutation Consequence to protein Families Ancestry
c.481C4T1 p.R161X PPK04, PPK07, PPK08, PPK09 Slovenian and Arab-Israeli
c.566C4G p.S189X PPK05, PPK06 Slovenian
c.58-68delGACCAGCTGGT p.D20Pfs*2 PPK02 Israeli
c.472delG2 p.G158Efs*1 PPK11 Canadian
c.562-563insTC p.N188Sfs*3 PPK01 Israeli
c.295insG p.L99Afs*9 PPK12 Israeli
c.639delA pA213Afs*29 PPK10 Slovenian
1Mutation previously reported by Pohler et al., 2012, Giehl et al., 2012, Cui et al., 2013, and Kiritsi et al., 2013.
2Mutation previously reported by Pohler et al., 2012 and Pohler et al., 2013.
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identified in patients with punctate PPK.
Although PPK is a rare disorder, diseases
characterized by hyperkeratosis and
hyperproliferation are common, and
identification of the underlying cellular
mechanisms in this familial keratoderma
may contribute to our future ability to
understand and treat the more prevalent
hyperkeratotic diseases.
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TO THE EDITOR
Olmsted syndrome (OS; MIM 614594)
is a rare genodermatosis featuring
symmetric and mutilating palmoplantar
keratoderma (PPK) and periorificial ker-
atotic plaques (Olmsted, 1927). Diffuse
alopecia, onychodystrophy, oral leuco-
keratosis, corneal lesions, and pseudo-
ainhum may be associated as well
(Mevorah et al., 2005; Lai-Cheong
et al., 2012). Extracutaneous manifesta-
tions are uncommon and include
deafness, mental retardation, joint
laxity, osteopenia, and osteolysis, se-
condary infections, and squamous cell
carcinoma developing in areas of PPK
(Mevorah et al., 2005).
Although most cases reported to date
have been sporadic, both autosomal
dominant (Cambiaghi et al., 1995) and
X-linked recessive inheritance (Larregue
et al., 2000; Haghighi et al., 2013)
have been reported and shown to
be associated with mutations in
TRPV3 (MIM 607066) which encodes
the transient receptor potential
vanilloid 3 (Lai-Cheong et al., 2012;
Lin et al., 2012) and X-linked
MBTPS2 (MIM 300294), encoding the
membrane-bound transcription factor
protease, site 2, respectively (Haghighi
et al., 2013).
TRPV3 is highly expressed in kerati-
nocytes and in cells outlining hair
follicles (Valdes-Rodriguez et al.,
2013). It has an important role in
epidermal barrier formation (Cheng
et al., 2010), modulates hair growthAccepted article preview online 24 January 2013; published online 20 February 2014
Abbreviations: OS, Olmsted syndrome; PPK, palmoplantar keratoderma; RFLP, restriction fragment length
polymorphism; TRPV, vanilloid family of transient receptor potential
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